The efficacy of structured self-monitoring of blood glucose (SMBG)on glycemic control in non-insulin treated type 2 diabetes
Not Applicable
Completed
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000008965
- Lead Sponsor
- Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1. insulin or GLP-1 receptor agonists-treated patients 2. pregnancy 3. alcoholism, depression, mental diseases 4. Abnormal Hemoglobin 5. Severe complications and comorbidities 6. Malignancy 7. Treatment changes in 2 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in HbA1c in 6 months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie structured SMBG's impact on glycemic control in type 2 diabetes?
How does structured SMBG compare to continuous glucose monitoring in non-insulin treated T2DM patients?
Which biomarkers correlate with improved HbA1c outcomes following structured SMBG implementation?
What adverse events are associated with structured SMBG adherence in type 2 diabetes management?
Are there combination therapies that enhance structured SMBG efficacy for T2DM patients?